- Home
- SNBR vs BDTX Comparison
SNBR vs BDTX Comparison
Compare SNBR & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNBR
- BDTX
- Stock Information
- Founded
- SNBR 1987
- BDTX 2014
- Country
- SNBR United States
- BDTX United States
- Employees
- SNBR N/A
- BDTX N/A
- Industry
- SNBR Home Furnishings
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNBR Consumer Discretionary
- BDTX Health Care
- Exchange
- SNBR Nasdaq
- BDTX Nasdaq
- Market Cap
- SNBR 154.1M
- BDTX 132.5M
- IPO Year
- SNBR 1998
- BDTX 2020
- Fundamental
- Price
- SNBR $7.39
- BDTX $2.94
- Analyst Decision
- SNBR Hold
- BDTX Strong Buy
- Analyst Count
- SNBR 2
- BDTX 6
- Target Price
- SNBR $9.00
- BDTX $14.83
- AVG Volume (30 Days)
- SNBR 478.8K
- BDTX 1.2M
- Earning Date
- SNBR 07-30-2025
- BDTX 08-05-2025
- Dividend Yield
- SNBR N/A
- BDTX N/A
- EPS Growth
- SNBR N/A
- BDTX N/A
- EPS
- SNBR N/A
- BDTX 0.09
- Revenue
- SNBR $1,605,108,000.00
- BDTX $70,000,000.00
- Revenue This Year
- SNBR N/A
- BDTX N/A
- Revenue Next Year
- SNBR $4.27
- BDTX N/A
- P/E Ratio
- SNBR N/A
- BDTX $33.49
- Revenue Growth
- SNBR N/A
- BDTX N/A
- 52 Week Low
- SNBR $4.48
- BDTX $1.20
- 52 Week High
- SNBR $20.75
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- SNBR 45.46
- BDTX 70.75
- Support Level
- SNBR $7.44
- BDTX $2.43
- Resistance Level
- SNBR $8.44
- BDTX $2.72
- Average True Range (ATR)
- SNBR 0.60
- BDTX 0.18
- MACD
- SNBR 0.10
- BDTX 0.03
- Stochastic Oscillator
- SNBR 49.52
- BDTX 93.66
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.